Fact CheckerSign in

NCT05744271Completed

Evaluation of FES+VFBT With Individuals With Lived Experience

Source: ClinicalTrials.gov · Last updated 19 Mar 2026

Brief summary (registry, in English)

Falls are a concern for people living with spinal cord injury (SCI) or stroke. Falls may result in injury and a fear of falling, which often cause people to restrict their mobility and daily activities. Despite its importance, fall prevention for people with SCI or stroke has not been studied in detail, and as a result, there is a lack of treatments to address their high fall risk. Functional electrical stimulation (FES) is the application of a mild electrical stimulus to a muscle that helps it move better. In this study, the MyndSearch device will be used to deliver FES. The visual feedback balance training (VFBT) is similar to playing a video game on a balance board while following visual cues on a screen. The purpose of this study is to evaluate an intervention that combines FES and VFBT to improve balance and lead to the recovery of safe mobility in individuals living with neurological disease or injury (e.g., spinal cord injury, stroke).

Status (registry)
Completed
Study type
Interventional
Enrollment
18 (actual)
First submitted
18 Jan 2023
Start date
1 Apr 2023
Primary completion date
22 May 2025
Lead sponsor
University Health Network, Toronto
Diseases
Stroke
NCT number
NCT05744271

What you commit to

  • Study type: Interventional
  • Participants enrolled: 18
  • From 1 Apr 2023 to the primary completion date, 22 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • a prior lower extremity fragility fracture

Other illness

  • contraindications for FES (i.e. implanted electronic device, active cancer or radiation in past six months, uncontrolled epilepsy, skin rash/wound at an electrode site, pregnancy, active deep vein thrombosis)31
  • contraindications for TMS (i.e. history of epilepsy and/or seizures)

Other

  • an injection of botulinum toxin to leg muscles in the past two weeks or injection planned during treatment period
  • peripheral nerve damage in the legs

Who the study is looking for

  • Individuals with a non-progressive, motor incomplete SCI/D (i.e. American Spinal Injury Association Impairment Scale (AIS) C or D) or a middle cerebral artery (MCA) stroke
  • chronic stage of recovery (i.e. \>1 year post-SCI/D or stroke), when natural recovery has plateaued
  • ≥18 years old
  • able to stand independently for 60 seconds
  • moderate level of trunk control as evidenced by the ability to reach forward \>2 inches in standing (i.e. score of 1-3 on the Berg Balance Scale Reaching Forward task);
  • free of any other condition besides SCI/D or stroke that significantly affects walking or balance (e.g., no vestibular disorder, significant vision loss)
  • able to understand spoken English

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
KITE-Toronto Rehabilitation Institute
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.